View of Assessment of the Effectiveness of Glp-1 Agonists in Non-Alcoholic Fatty Liver Disease Associated With Obesity and Insulin Resistance

Return to Article Details Assessment of the Effectiveness of Glp-1 Agonists in Non-Alcoholic Fatty Liver Disease Associated With Obesity and Insulin Resistance Download Download PDF